Perspective on treatment for unresectable locally advanced non-small cell lung cancer with oncogene-driven mutation: a narrative review

The standard treatment of unresectable locally advanced non-small cell lung cancer (LA NSCLC) is concurrent chemoradiotherapy. With the addition of immunotherapy, patients with LA NSCLC received a significantly prolonged outcome, while patients with harboring epidermal growth factor receptor (EGFR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Liyang, Meng, Xiangjiao, Zhao, Xianguang, Xing, Ligang, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653115/
https://www.ncbi.nlm.nih.gov/pubmed/33209632
http://dx.doi.org/10.21037/tlcr-20-722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653115/
https://www.ncbi.nlm.nih.gov/pubmed/33209632
http://dx.doi.org/10.21037/tlcr-20-722

Ejemplares similares